Browsing Tag
CDSCO approval
1 post
Eyestem Receives CDSCO Approval to Initiate Phase 2 Randomized, Controlled Human Trials of Eyecyte-RPE™
This milestone positions Eyestem at the forefront of developing investigational retinal pigment epithelium (RPE) cell therapy, Eyecyte-RPE™
